Literature DB >> 17699557

Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation.

David A Vesey1, Wade A Kruger, Philip Poronnik, Glenda C Gobé, David W Johnson.   

Abstract

Despite the abundant expression of protease-activated receptor (PAR)-2 in the kidney, its relevance to renal physiology is not well understood. A role for this receptor in inflammation and cell proliferation has recently been suggested in nonrenal tissues. The aims of this study were to demonstrate that human proximal tubule cells (PTC) express functional PAR-2 and to investigate whether its activation can mediate proinflammatory and proliferative responses in these cells. Primary human PTC were cultured under serum-free conditions with or without the PAR-2-activating peptide SLIGKV-NH2 (up to 800 microM), a control peptide, VKGILS-NH2 (200 microM), or trypsin (0.01-100 nM). PAR-2 expression (RT-PCR), intracellular Ca2+ mobilization (fura-2 fluorimetry), DNA synthesis (thymidine incorporation), fibronectin production (ELISA, Western blotting), and monocyte chemotactic protein (MCP)-1 secretion (ELISA) were measured. Trypsinogen expression in kidney and PTC cultures was determined by immunohistochemistry and Western blotting. In the kidney PTC were the predominant cell type expressing PAR-2. SLIGKV-NH2, but not VKGILS-NH2, stimulated a rapid concentration-dependent mobilization of intracellular Ca2+ and ERK1/2 phosphorylation and, by 24 h, increases in DNA synthesis, fibronectin secretion, and MCP-1 secretion. These delayed responses appeared to be independent of ERK1/2. Trypsin produced similar rapid but not delayed responses. Trypsinogen was weakly expressed by PTC in the kidney and in culture. In summary, PTC are the main site of PAR-2 expression in the human kidney. In PTC cultures SLIGKV-NH2 initiates proinflammatory and proliferative responses. Trypsinogen expressed within the kidney has the potential to contribute to PAR-2 activation in certain circumstances.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17699557     DOI: 10.1152/ajprenal.00088.2007

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  10 in total

1.  Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2).

Authors:  Rithwik Ramachandran; Koichiro Mihara; Hyunjae Chung; Bernard Renaux; Chang S Lau; Daniel A Muruve; Kathryn A DeFea; Michel Bouvier; Morley D Hollenberg
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

Review 2.  New insights into sodium transport regulation in the distal nephron: Role of G-protein coupled receptors.

Authors:  Luciana Morla; Aurélie Edwards; Gilles Crambert
Journal:  World J Biol Chem       Date:  2016-02-26

3.  Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110).

Authors:  J Y Suen; G D Barry; R J Lohman; M A Halili; A J Cotterell; G T Le; D P Fairlie
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

4.  Proteinase-activated receptor-2 transactivation of epidermal growth factor receptor and transforming growth factor-β receptor signaling pathways contributes to renal fibrosis.

Authors:  Hyunjae Chung; Rithwik Ramachandran; Morley D Hollenberg; Daniel A Muruve
Journal:  J Biol Chem       Date:  2013-11-19       Impact factor: 5.157

5.  PAR2 Modulators Derived from GB88.

Authors:  Mei-Kwan Yau; Ligong Liu; Jacky Y Suen; Junxian Lim; Rink-Jan Lohman; Yuhong Jiang; Adam J Cotterell; Grant D Barry; Jeffrey Y W Mak; David A Vesey; Robert C Reid; David P Fairlie
Journal:  ACS Med Chem Lett       Date:  2016-10-10       Impact factor: 4.345

6.  Pathway-selective antagonism of proteinase activated receptor 2.

Authors:  J Y Suen; A Cotterell; R J Lohman; J Lim; A Han; M K Yau; L Liu; M A Cooper; D A Vesey; D P Fairlie
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

7.  Neuroprotective effect of protease-activated receptor-2 in the hypoxia-induced apoptosis of rat RGC-5 cells.

Authors:  Yanli Peng; Jiaping Zhang; Haiwei Xu; Jianrong He; Xi Ying; Yi Wang
Journal:  J Mol Neurosci       Date:  2012-09-05       Impact factor: 3.444

8.  Expression of protease activated receptor-2 is reduced in renal cell carcinoma biopsies and cell lines.

Authors:  Christudas Morais; Retnagowri Rajandram; Jade S Blakeney; Abishek Iyer; Jacky Y Suen; David W Johnson; Glenda C Gobe; David P Fairlie; David A Vesey
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

9.  PR3 and elastase alter PAR1 signaling and trigger vWF release via a calcium-independent mechanism from glomerular endothelial cells.

Authors:  Samantha P Tull; Anne Bevins; Sahithi Jyothsna Kuravi; Simon C Satchell; Bahjat Al-Ani; Stephen P Young; Lorraine Harper; Julie M Williams; George Ed Rainger; Caroline O S Savage
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

10.  Tissue kallikrein mediates pro-inflammatory pathways and activation of protease-activated receptor-4 in proximal tubular epithelial cells.

Authors:  Wai Han Yiu; Dickson W L Wong; Loretta Y Y Chan; Joseph C K Leung; Kwok Wah Chan; Hui Yao Lan; Kar Neng Lai; Sydney C W Tang
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.